Form 4: BioNTech SE CEO Sells Shares
Insider Transaction (Form 4)
Ugur Sahin, Chief Executive Officer and 10% owner of BioNTech SE, sold 79,000 shares of common stock on September 21, 2026.
Summary
- Open-market sale: disposed of 33,000 Ordinary Shares at $97.81 ($3,227,720) on September 21, 2026; holds 456,209 after (Direct).
- Open-market sale: disposed of 46,000 Ordinary Shares at $100.72 ($4,633,037) on September 22, 2026; holds 410,209 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $7,860,757 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Ugur Sahin — Officer (Chief Executive Officer), 10% owner
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-21 | Open-market sale | Ordinary Shares | 33,000 | $98 | $3.2M | 456,209 |
| 2026-09-22 | Open-market sale | Ordinary Shares | 46,000 | $101 | $4.6M | 410,209 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-21 | Open-market sale (33,000 shares) |
| 2026-09-22 | Open-market sale (46,000 shares) |
Keywords
insider transaction, Form 4, BNTX, BioNTech SE, bearish, Ugur Sahin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.